Working… Menu
Trial record 1 of 2 for:    BRAVO | Multiple Sclerosis | Italy
Previous Study | Return to List | Next Study

BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) (BRAVO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00605215
Recruitment Status : Completed
First Posted : January 30, 2008
Last Update Posted : August 26, 2013
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2011
Actual Study Completion Date : December 2011
Certification/Extension First Submitted : August 16, 2013